Cibus, Inc. Class A Common Stock

Day range

$1.02 – $1.14

Open

$1.08

Prev close

$1.09

Volume

148.9K

Market cap

$86.6M

Shares out

76.43M

P/E

—

P/S

19.16

P/B

5.63

P/FCF

—

ROE

-663.4%

ROA

-31.3%

Debt/Equity

0.06

Div yield

0.00%

As of Nov 12, 2026

• Business updateNov 12, 2026

  On November 12, 2026, Cibus, Inc. (the "Company") announced its financial results for the three months ended September 30, 2026, and provided a business update.

• Director departureJun 9, 2026

  Concurrently with the appointment, Mr. Wichner resigned from the Board and from the Strategy Committee of the Board. To facilitate the Chief Executive Officer transition and related Board transition designed to enhance the independence of the Board, Dr. Beetham resigned from the Board also effective June 8, 2026.

• Annual meeting resultsJun 5, 2026

  As a result, at the Annual Meeting, Mark Finn, Peter Beetham, Kimberly A. Box, Jean-Pierre Lehmann, August Moretti, Gerhard Prante, Rory Riggs, Thomas Urban, and Craig Wichner were elected as directors of the Company, each to serve a one-year term, the compensation of Company's named executive officers was approved (on an advisory basis), and the appointment of BDO USA, P.C. was ratified.

• Executive compensation changeApr 10, 2026

  Pursuant to the Company's Non-Employee Director Compensation Policy, the Board agreed to provide Mr. Urban with annual compensation comprising (i) a cash retainer equal to $60,000, payable semi-annually, and (ii) subject to Board approval and granting pursuant to the terms and provisions of the Cibus, Inc. 2017 Omnibus Incentive Plan, as amended, equity compensation with a grant date value equal to $90,000.

• Underwriting agreementMar 27, 2026

  Pursuant to the Underwriting Agreement, the Underwriter will receive an underwriting discount of 7.0% of the gross proceeds received from the sale of the Shares in this Offering. In addition, the Company has agreed to reimburse the Underwriter for reasonable and documented out-of-pocket legal and other expenses incurred by them in connection with the Offering in an amount not to exceed $150,000.

Days to cover

61.8

Short interest

3.08M

Avg volume

49.86K

As of Oct 30, 2026 · reported to FINRA twice monthly.

• Cibus (CBUS) Reports Q3 Loss, Lags Revenue Estimates
  negativeZacks Investment Research· Nov 12, 2026
• Dole (DOLE) Q3 Earnings Miss Estimates
  negativeZacks Investment Research· Nov 9, 2026
• Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
  positiveGlobeNewswire Inc.· Jun 8, 2026
• Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
  positiveGlobeNewswire Inc.· May 4, 2026
• Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative
  positiveGlobeNewswire Inc.· Feb 6, 2026